Bronchial Artery Embolization for Life-Threatening Hemoptysis in COVID-19 Patients.

Publication date: Dec 01, 2024

After the outbreak of the novel coronavirus at the end of December 2019 in China, it has become a global pandemic. Clinical manifestation of coronavirus disease 2019 (COVID-19) has a wide range of presentations from asymptomatic to severe multi-organ involvement. Hemoptysis appears to be one of the major manifestations of severe acute respiratory syndrome that is related to COVID-19 infection. The occurrence of hemoptysis is multifactorial. However, massive hemoptysis is usually related to pulmonary aspergillosis or severe bronchiectasis due to corticosteroid pulse therapy that can be life-threatening. This manuscript presents five cases of successful life-saving bronchial artery embolization in patients with COVID-19 infection who were suffering from massive hemoptysis that was mostly related to aspergillosis and bronchiectasis. These cases are followed by a review of the literature.

Open Access PDF

Concepts Keywords
China angioembolization
Coronavirus bronchiectasis
December embolization
Massive hemoptysis
Therapy invasive pulmonary aspergillosis
polyvinyl alcohol
SARS-Cov-2

Semantics

Type Source Name
disease MESH COVID-19
disease MESH severe acute respiratory syndrome
disease MESH infection
disease MESH pulmonary aspergillosis
disease MESH bronchiectasis
disease MESH aspergillosis
disease MESH invasive pulmonary aspergillosis
drug DRUGBANK Polyvinyl alcohol

Original Article

(Visited 3 times, 1 visits today)